RPRX

Royalty Pharma Plc

28.21

-0.03-0.11%

After Hours: 28.25 +0.04 +0.14%18:07 09/18 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE28.17/28.24

TODAY RANGE28.14-28.46

VOL1.21M

MARKET CAP16.74B

52 WEEK RANGE25.01-31.66

AVG VOL (3M)2.63M

% TURNOVER0.20%

TURNOVER--

P/E (TTM)18.75

% RANGE1.15%

EPS(TTM)1.504

P/E(FORWARD)7.27

P/B1.956

BVPS14.42

DIVIDEND0.8400

P/S5.35

BETA--

DIV YIELD2.98%

FREE FLOAT MKT CAP13.72B

SHARES OUTSTANDING593.46M

NEXT EARNINGS11/06-11/11

FREE FLOAT486.42M

LOT SIZE1

EX-DIV DATE08/16/2024

News

Press Releases

Financial Reports

Profile

Latest

Popular

Barron‘s·14h ago
S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag
NASDAQ·09/10 19:18
RPRX Breaks Above 3% Yield Territory
Seeking Alpha·09/10 02:11
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2024 Update
NASDAQ·09/04 03:14
Ascendis Pharma Reaches $150 Mln Royalty Funding Agreement With Royalty Pharma; Stock Drops
Dow Jones·09/03 21:14
Press Release: Royalty Pharma and Ascendis Pharma -2-
Reuters·09/03 21:06
ASCENDIS PHARMA AND ROYALTY PHARMA ENTER INTO $150 MILLION ROYALTY FUNDING AGREEMENT
Seeking Alpha·08/22 07:04
Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating
NASDAQ·08/16 14:42
First Week of April 2025 Options Trading For Royalty Pharma (RPRX)
Dow Jones·08/14 11:21
Royalty Pharma Price Target Raised to $51.00/Share From $50.00 by Goldman Sachs
Dow Jones·08/14 11:21
Royalty Pharma Is Maintained at Buy by Goldman Sachs
TipRanks·08/13 13:45
Buy Rating Affirmed for Royalty Pharma Amidst Strong Financials and Positive Growth Outlook
Seeking Alpha·08/13 12:52
Cytokinetics cut at Goldman Sachs on diminished strategic interest
TipRanks·08/12 03:02
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Royalty Pharma (RPRX)
Seeking Alpha·08/11 22:33
Royalty Pharma: Busy Putting Capital To Work
NASDAQ·08/09 14:20
Cytokinetics (CYTK) Q2 Loss Wider Than Expected, Pipeline in Focus

Same Industry

Name/Symbol

Change%

Price

Royalty Pharma Plc

RPRX

-0.11%

28.21

McKesson

MCK

-0.45%

511.62

Biogen Inc

BIIB

-0.31%

197.59

Amgen Inc

AMGN

+0.04%

332.92

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

0.00%

0.0300

Lilly Eli & Co

LLY

-0.13%

904.97

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

-3.49%

1.660

Johnson & Johnson

JNJ

-0.55%

166.15

Abbvie Inc

ABBV

-0.26%

192.94

Zoetis Inc

ZTS

+0.39%

196.48

Gilead Sciences Inc

GILD

+1.01%

83.89

Novo-Nordisk A/S

NVO

+0.05%

132.06

Bristol-Myers Squibb Co

BMY

+0.51%

49.74

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.27%

29.75

Sanofi FR

SNY

+0.98%

57.47

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+0.23%

115.97

Dr Reddys Labs

RDY

-0.93%

78.79

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.